INTEC PHARMA LTD. Deferred Tax Assets, Valuation Allowance
INTEC PHARMA LTD. had Deferred Tax Assets, Valuation Allowance of $47.50 million as of 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2021-03-16
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $47.50M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $44.02M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $32.68M.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $22.77M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2020-12-31 | $47.50M 10-K · filed 2021-03-16 |
| 2019-12-31 | $44.02M 10-K · filed 2021-03-16 |
| 2018-12-31 | $32.68M 10-K · filed 2021-03-16 |
| 2017-12-31 | $22.77M 10-K · filed 2020-03-13 |
| 2016-12-31 | $15.34M 10-K · filed 2019-02-27 |